Acquisition History / Sun Pharmaceutical Industries Ltd / Organon & Co
Sun Pharmaceutical Industries Ltd Acquires Organon & Co
Announced April 27, 2026 — $11.75B
What happened
Sun Pharma agreed to acquire New York-listed Organon & Co in an all-cash deal valuing it at about $11.75 billion including debt, in one of India's biggest outbound acquisitions. Shareholders receive $14.00 per share, a premium of more than 24% to the prior close. Organon brings more than 70 women's health and general medicine products sold in 140 countries; it carried $8.6 billion of debt at end-2025.
- Target
- Organon & Co
- Announced
- April 27, 2026
- Price
- $11.75B
- Industry
- Pharmaceuticals / women's health
- Buyer type
- Strategic acquirer
- Status
- Announced, not yet closed
By the numbers
Frequently Asked Questions About This Acquisition
When did Sun Pharmaceutical Industries Ltd acquire Organon & Co?
Sun Pharmaceutical Industries Ltd acquired Organon & Co on April 27, 2026. This was Sun Pharmaceutical Industries Ltd's 1st publicly tracked acquisition out of 1 we have on record.
How much did Sun Pharmaceutical Industries Ltd pay for Organon & Co?
Sun Pharmaceutical Industries Ltd paid $11.75B for Organon & Co.
What does Organon & Co do?
Sun Pharma agreed to acquire New York-listed Organon & Co in an all-cash deal valuing it at about $11.75 billion including debt, in one of India's biggest outbound acquisitions. Shareholders receive $14.00 per share, a premium of more than 24% to the prior close. Organon brings more than 70 women's health and general medicine products sold in 140 countries; it carried $8.6 billion of debt at end-2025.
What other Pharmaceuticals / women's health companies has Sun Pharmaceutical Industries Ltd acquired?
Organon & Co is Sun Pharmaceutical Industries Ltd's only publicly tracked acquisition in Pharmaceuticals / women's health so far.